Fewer than 4 quarters available; TTM falls back to the latest annual figure.
Financials are reported in CAD; the price is in USD (the listing's quote basis differs from the reporting currency — an ADR over a non-USD reporter, or a native venue quoting in a sub-unit like pence). Price-based valuation (market cap, P/E, EV multiples, yields, WACC, and the market-cap-dependent Altman/Merton scores) is suppressed to avoid a cross-currency number. Currency-neutral ratios and returns are unaffected.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
P/E
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−44.7% (2026-06)
−115.8%
60th
+0.77σ
−36.9%
61 · 6
−21.0% (2026-06)
−24.8%
58th
+0.46σ
−15.4%
61 · 6
−75.8% (2026-06)
−201.7%
82nd
+0.87σ
−21.3%
73 · 7
−14.3%
−21.6%
49th
−0.40σ
5.1%
135 · 134
EPS Growth 3Y
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−3.1% (2026-06)
−16.4%
no band (37 mo · 4 distinct)
—
—
9.0%
37 · 4
Market Cap
$418.68M
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
ROE (point-in-time)Health Care median, same monthshaded = own p10–p90 · dashed = own median
Multiple-implied price ladder · Full
Filed earnings only.
no P/E ladder — P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Ladder not drawn for this name — the reason is above.ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
vs Health Care· 1054 names
No metric had a value here and enough covered peers.
Covered pool$977.78B +7.6%/yr 2020→2025Concentration484 of 10,000fragmented · top 3 hold 22.9% · −24 pts since 2020CGC0.0% · rank 111 of 348 · −0.0pp over 5y· CV 0.39 · σ 0.0pp
Who holds the poolCY2025 · bars scaled to the largest member
Growth, restated as sharewhere each pace has to END UP, by 2030
Its own realised pace— No growth rate was supplied to restate.
The pace the price requires— The growth today's price requires (our reverse-DCF) is a Pro metric — the realized-pace runway above is free.
CGC share over timelast 6 of 7 published years
Calendar year
2020
2021
2022
2023
2024
2025
Share of covered pool
0.1%
0.1%
0.0%
0.0%
0.0%
0.0%
coverage: 321 of the 385 members that…
Share of covered industry revenue · n=348 in Pharmaceuticals & Biotechnology · CY2025 pool · built 2026-08-19 not market shareⓘ
Covered filers only, not market share — private and uncovered companies are missing, so every share here reads high. Years are FX-converted and published only once most of the pool has filed.
